placebo
controlled
trial
cephalexin
therapy
ambulatory
management
patient
cystic
fibrosis
effect
oral
administration
cephalexin
evaluated
double
blind
placebo
controlled
crossover
study
patient
mild
moderate
pulmonary
disease
due
cystic
fibrosis
two
year
four
month
period
cephalexin
alternated
four
month
placebo
period
thus
patient
served
control
subject
fungal
vulvovaginitis
occurred
two
patient
cephalexin
therapy
year
study
rate
colonization
mucoid
strain
pseudomonas
aeruginosa
increased
disease
severity
deteriorated
patient
initially
colonized
p
aeruginosa
short
term
course
sputum
culture
specific
antibiotic
improved
course
patient
mild
moderate
pulmonary
disease
due
cystic
fibrosis
treatment
cephalexin
decreased
frequency
respiratory
illness
respiratory
illness
requiring
antibiotic
hospitalization
respiratory
illness
patient
initially
colonized
staphylococcus
aureus
haemophilus
influenzae
also
reduced
colonization
organism
improved
weight
gain
patient
associated
period
cephalexin
therapy
pulmonary
function
test
remained
stable
improved
patient
disease
severity
improved
patient
colonized
p
aeruginosa
